ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -30.0% | 208 | 0.0% | 0.01% | +150.0% |
| Q1 2022 | $10,000 | -28.6% | 208 | +1.0% | 0.00% | -33.3% |
| Q4 2021 | $14,000 | +7.7% | 206 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $13,000 | -23.5% | 206 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $17,000 | +21.4% | 206 | -4.6% | 0.00% | +33.3% |
| Q1 2021 | $14,000 | -61.1% | 216 | -53.6% | 0.00% | -57.1% |
| Q4 2020 | $36,000 | +80.0% | 466 | +2.2% | 0.01% | +75.0% |
| Q3 2020 | $20,000 | +17.6% | 456 | +12.6% | 0.00% | 0.0% |
| Q2 2020 | $17,000 | +54.5% | 405 | +2.0% | 0.00% | +33.3% |
| Q1 2020 | $11,000 | -56.0% | 397 | -1.2% | 0.00% | -40.0% |
| Q4 2019 | $25,000 | +150.0% | 402 | +17.5% | 0.01% | +150.0% |
| Q3 2019 | $10,000 | – | 342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |